STEPHEN DAVIS Insider Trading
Get free email notifications about insider trading for STEPHEN DAVIS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEPHEN DAVIS. STEPHEN DAVIS is a Director in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and a Exec. VP, Chief Oper. Officer in NEUROGEN CORP ($NRGN) and a President in NEUROGEN CORP ($NRGN) and a President, CEO in NEUROGEN CORP ($NRGN) and a Sr VP, Chief Business Officer in NEUROGEN CORP ($NRGN) and a Sr VP, Chief Operating Officer in NEUROGEN CORP ($NRGN) and a Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and a CEO in ACADIA PHARMACEUTICALS INC ($ACAD) and a INTERIM CEO in ACADIA PHARMACEUTICALS INC ($ACAD) and a PRESIDENT AND CEO in ACADIA PHARMACEUTICALS INC ($ACAD) and a Director in BELLICUM PHARMACEUTICALS, INC ($BLCM).
Address: 35 NE INDUSTRIAL RD. BRANFORD 06405 CT
Companies in which STEPHEN DAVIS is an Insider
ACADIA PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEPHEN DAVIS: PRESIDENT AND CEO, INTERIM CEO
Holdings: 57,162 shares
Current Value: $2,183,017
Latest Transaction: Apr 30 2021
$ACAD Market Capitalization: $4.67B
$ACAD Previous Close: $38.19
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BELLICUM PHARMACEUTICALS, INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEPHEN DAVIS: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 16 2020
$BLCM Market Capitalization: $335.83M
$BLCM Previous Close: $12.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
HERON THERAPEUTICS, INC. /DE/
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEPHEN DAVIS: Director
Holdings: 3,000 shares
Latest Transaction: Dec 23 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NEUROGEN CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEPHEN DAVIS: President, CEO, President, Exec. VP, Chief Oper. Officer, Sr VP, Chief Operating Officer, Sr VP, Chief Business Officer
Holdings: 5,979 shares
Latest Transaction: Jul 29 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SYNAGEVA BIOPHARMA CORP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of STEPHEN DAVIS: Director
Holdings: 0 shares
Latest Transaction: Jun 23 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of STEPHEN DAVIS
Sentiment: All, ACAD, BLCM, HRTX, NRGN, GEVA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30 2021 | ACAD | ACADIA PHARMACEUTI ... | DAVIS STEPHEN | CEO | Option Exercise | M | 0.00 | 15,625 | 0 | 31,250 | |
| Apr 30 2021 | ACAD | ACADIA PHARMACEUTI ... | DAVIS STEPHEN | CEO | Sell | S | 20.33 | 7,850 | 159,591 | 49,312 | 57.2 K to 49.3 K (-13.73 %) |
| Apr 30 2021 | ACAD | ACADIA PHARMACEUTI ... | DAVIS STEPHEN | CEO | Buy | M | 0.00 | 15,625 | 0 | 57,162 | 41.5 K to 57.2 K (+37.62 %) |
| Feb 25 2021 | ACAD | ACADIA PHARMACEUTI ... | DAVIS STEPHEN | CEO | Option Exercise | A | 0.00 | 43,782 | 0 | 43,782 | |
| Feb 25 2021 | ACAD | ACADIA PHARMACEUTI ... | DAVIS STEPHEN | CEO | Option Exercise | A | 49.74 | 161,230 | 8,019,580 | 161,230 | |
| Feb 08 2021 | ACAD | ACADIA PHARMACEUTI ... | DAVIS STEPHEN | CEO | Option Exercise | A | 21.28 | 23,750 | 505,400 | 23,750 | |
| Feb 08 2021 | ACAD | ACADIA PHARMACEUTI ... | DAVIS STEPHEN | CEO | Option Exercise | A | 35.80 | 40,625 | 1,454,375 | 40,625 |